Because the causes of inflammation vary widely, GLP-1 and GLP-1/GIP medications meaningfully improve some inflammatory pathways (especially metabolically driven inflammation)but not all., This guide explains: How inflammation shows up in different organ systems Which inflammatory pathways semaglutide and tirzepatide actually improve Why they do not treat autoimmune disease, fibromyalgia, or chronic pain What early research suggestsand why we must be cautious What Is Inflammation
The titration schedule means you spend the first 4-8 weeks ramping up to your working dose, with the most aggressive fat loss occurring in weeks 8-20 when you are at maintenance dose
Exercise tolerance improvements appear in some reports, with users describing better endurance and reduced breathlessness during cardiovascular activities
Both are short-acting tesamorelins half-life is roughly 1837 minutes and sermorelins about 1020 minutes which is why studied dosing is once-daily subcutaneous injection
Your GP or specialist will work with you to determine the most appropriate duration based on your treatment goals, response to therapy, and ability to maintain improvements through lifestyle measures alone